Patient Characteristics
| Patient Characteristics | N (%) |
|---|---|
| Age (years), Median (range) | 53 (39–76) |
| Sex | |
| Male | 5 (63) |
| Female | 3 (37) |
| Race | |
| White | 7 (88) |
| Black | 1 (12) |
| Histology | |
| Thymoma | 7 (88) |
| B1 | 1 |
| B2 | 3 |
| B3 | 3 |
| Thymic carcinoma | 1 (12) |
| Stage at presentation | |
| IVA | 1 (12) |
| IVB | 7 (88) |
| Previous treatment | |
| Systemic therapya, Median (range) | 3.5 (2–10) |
| Thymectomyb | 7 (88) |
| Chest radiation therapy | 7 (88) |
a Includes: Cisplatin + Doxorubicin + Cyclophosphamide (PAC), PAC + Prednisone, PAC + Belinostat, Cisplatin + Etoposide, Carboplatin + Etoposide, Carboplatin + Paclitaxel, Gemcitabine + Capecitabine, Cisplatin, Paclitaxel, Gemcitabine, Pemetrexed, Sunitinib, Cixutumumab, Milciclib, Octreotide, Amrubicin, Saracatinib, and Belinostat. bIncludes one case of debulking surgery